Natixis Advisors, L.P. Abcam PLC Transaction History

Natixis Advisors, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$12.62 - $24.47 $2.68 Million - $5.2 Million	212,543 Added 65.77%	535,717 $13.1 Million
Q1 2023 May 11, 2023	SELL	$12.98 - $17.1 $2.83 Million - $3.73 Million	-217,858 Reduced 40.27%	323,174 $4.35 Million
Q4 2022 Jan 27, 2023	BUY	$13.92 - $17.0 $2.01 Million - $2.45 Million	144,183 Added 36.33%	541,032 $8.42 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $1.43 Million - $1.79 Million	106,848 Added 36.84%	396,849 $5.95 Million
Q2 2022 Aug 12, 2022	BUY	$12.69 - $19.25 $531,165 - $805,747	41,857 Added 16.87%	290,001 $4.19 Million
Q1 2022 May 12, 2022	SELL	$15.5 - $23.89 $414,098 - $638,245	-26,716 Reduced 9.72%	248,144 $4.54 Million
Q4 2021 Feb 08, 2022	BUY	$20.04 - $23.84 $580,859 - $691,002	28,985 Added 11.79%	274,860 $6.47 Million
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $399,809 - $495,506	23,004 Added 10.32%	245,875 $4.98 Million
Q2 2021 Aug 12, 2021	BUY	$18.47 - $22.11 $588,343 - $704,291	31,854 Added 16.68%	222,871 $4.24 Million
Q1 2021 May 05, 2021	BUY	$19.22 - $24.3 $1.66 Million - $2.1 Million	86,270 Added 82.36%	191,017 $3.67 Million
Q4 2020 Feb 12, 2021	BUY	$18.2 - $22.45 $1.91 Million - $2.35 Million	104,747 New	104,747 $2.26 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.